Author response for 'Real‐world evidence following a mandatory treatment break after a 1‐year prophylactic treatment with calcitonin gene‐related peptide (pathway) monoclonal antibodies'
العنوان: | Author response for 'Real‐world evidence following a mandatory treatment break after a 1‐year prophylactic treatment with calcitonin gene‐related peptide (pathway) monoclonal antibodies' |
---|---|
المؤلفون: | null Michael Nsaka, null Armin Scheffler, null Sebastian Wurthmann, null Hannah Schenk, null Christoph Kleinschnitz, null Martin Glas, null Dagny Holle |
بيانات النشر: | Wiley, 2022. |
سنة النشر: | 2022 |
الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_________::d55d4ffa7e47045c4ba2d93dfcce7379Test https://doi.org/10.1002/brb3.2662/v2/response1Test |
رقم الانضمام: | edsair.doi...........d55d4ffa7e47045c4ba2d93dfcce7379 |
قاعدة البيانات: | OpenAIRE |
الوصف غير متاح. |